Kathleen C. Kobashi, MD, FACS Head, Section of Urology and Renal Transplantation Virginia Mason Medical Center, Seattle, WA

Similar documents
Anatomical and Functional Results of Pelvic Organ Prolapse Mesh Repair: A Prospective Study of 105 Cases

Tools for Evaluation. Urodynamics Case Studies. Case 1. Evaluation. Case 1. Bladder Diary SUI 19/01/2018

Urogynecology Office. Can You Hold? An Update on the Treatment of OAB. Can You Hold? Urogynecology Office

Urodynamics Mismatch - Should We Listen to the Study, or the Patient?

Operative Approach to Stress Incontinence. Goals of presentation. Preoperative evaluation: Urodynamic Testing? Michelle Y. Morrill, M.D.

Summary. Neuro-urodynamics. The bladder cycle. and voiding. 14/12/2015. Neural control of the LUT Initial assessment Urodynamics

Urogynecology in EDS. Joan L. Blomquist, MD Greater Baltimore Medical Center August 2018

URODYNAMICS IN MALE LUTS: NECESSARY OR WASTE OF TIME?

Objectives. Prevalence of Urinary Incontinence URINARY INCONTINENCE: EVALUATION AND CURRENT TREATMENT OPTIONS

TREATMENT OF OVERACTIVE BLADDER IN ADULTS FUGA 2016 KGH

Content. Terminology Anatomy Aetiology Presentation Classification Management

Prolapse & Urogynaecology. Hester Mannion and Fabi Sica

PRE-OPERATIVE URODYNAMIC

Urinary Incontinence. Vibhash Mishra Consultant Urological Surgeon Royal Free Hospital

LUTS after TURP: How come and how to manage? Matthias Oelke

BREAK FREE. from Pelvic Floor Disorders WELCOME & INTRODUCTION 11/6/2017. Heidi Brown, Sarah McAchran, MD. Dobie Giles, MD, MS

Mr. GIT KAH ANN. Pakar Klinikal Urologi Hospital Kuala Lumpur.

Outcomes of Midurethral Slings in Women with Concomitant Preoperative Severe Lower Urinary Tract Voiding Symptoms

Incontinence; Lets talk about it. Karanvir Virk M.D. Minimally Invasive and Pelvic Reconstructive Surgery

Subject: Percutaneous Tibial Nerve Stimulation

Neuromodulation and the pudendal nerve

THE ACONTRACTILE BLADDER - FACT OR FICTION?

Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline.

Botulinum Toxin Injection for OAB: Indications & Technique

The Evidence for Antimuscarinic Agents in Female Mixed Urinary Incontinence

Various Types. Ralph Boling, DO, FACOG

MEDICAL POLICY SUBJECT: PERCUTANEOUS POSTERIOR TIBIAL NERVE STIMULATION (PPTNS)

Overactive Bladder: Identifying Patients at Risk, Implementing New Strategies

Practical urodynamics What PA s need to know. Gary E. Lemack, MD Professor of Urology and Neurology

Management of LUTS after TURP and MIT

NON-Neurogenic Chronic Urinary Retention AUA White Paper

Diagnostic approach to LUTS in men. Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center

Urodynamics in women. Aims of Urodynamics in women. Why do Urodynamics?

OAB Treatment Guidelines

Advanced Care for Female Overactive Bladder & Urinary Incontinence. Department of Urology Kaiser Permanente Santa Rosa

Female Urinary Incontinence

Options for Vaginal Prolapse. What is prolapse? What is prolapse? Disclosures 10/23/2013. Michelle Y. Morrill, M.D. None

Ben Herbert Alex Wojtowicz

Index. Note: Page numbers of article titles are in boldface type.

MEDICAL POLICY SUBJECT: PERCUTANEOUS POSTERIOR TIBIAL NERVE STIMULATION (PPTNS) POLICY NUMBER: CATEGORY: Technology Assessment

Association of BPH with OAB: The Plumbing or the Pump?

Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist

Prediction and prevention of stress urinary incontinence after prolapse surgery van der Ploeg, J.M.

INJ. Original Article INTRODUCTION. Int Neurourol J 2010;14: doi: /inj pissn eissn

Overactive bladder symptoms after midurethral sling surgery in women: Risk factors and management

Diagnosis and Mangement of Nocturia in Adults

Overactive Bladder: Diagnosis and Approaches to Treatment

Neurogenic bladder. Neurogenic bladder is a type of dysfunction of the bladder due to neurological disorder.

Posterior Tibial Nerve Stimulation

Bladder dysfunction in ALD and AMN

Comparison of midurethral sling outcomes with and without concomitant prolapse repair

Adult Urodynamics: American Urological Association (AUA)/Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) Guideline

Posterior Tibial Nerve Stimulation for Voiding Dysfunction

Botulinum Toxin: Applications in Urology

The patient, your co-pilot in assessing LUTS

Pelvic Floor Therapy for the Neurologic Client Carina Siracusa, PT, DPT, WCS

Clinical Policy: Posterior Tibial Nerve Stimulation for Voiding Dysfunction Reference Number: CP.MP.133

Management, Evaluation, and Treatment of Overactive Bladder and Urinary Incontinence

9/24/2015. Pelvic Floor Disorders. Agenda. What is the Pelvic Floor? Pelvic Floor Problems

Urodynamic findings in women with insensible incontinence

April Clinical Focus Topic URINARY FREQUENCY

La vescica iperattiva: dalla diagnosi ai nuovi approcci terapeutici

URINARY INCONTINENCE

Incidence and Risk Factors of Postoperative De Novo Voiding Dysfunction following Midurethral Sling Procedures

Moneli Golara Consultant Obstetrician and Gynaecologist Royal Free NHS Trust Barnet Hospital

Managing Female Urinary Incontinence Within Primary Care

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

ASYMPTOMATIC MICROSCOPIC HEMATURIA IN WOMEN JOLYN HILL, MD ASSISTANT PROFESSOR, CLINICAL UROGYNECOLOGY FEBRUARY14, 2017

The new International Continence Society

김준철 가톨릭대학교의과대학비뇨기과학교실

NEUROMODULATION FOR UROGYNAECOLOGISTS

Urinary Incontinence for the Primary Care Provider

URINARY INCONTINENCE. Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara

Lower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics. Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital

Management of OAB. Lynsey McHugh. Consultant Urological Surgeon. Lancashire Teaching Hospitals

AGENDA. 8:00 AM 8:30 AM Pelvic Anatomy of the Lower Urinary Tract and the Anatomy and Physiology of Continence/Incontinence Mickey M.

Corporate Medical Policy

PREVENTING URINARY INCONTINENCE through PELVIC FLOOR REHABILITATION in DISABLED ELDERLY

ORIGINAL ARTICLE. Carlo Vecchioli Scaldazza 1, Carolina Morosetti 2, Rosita Giampieretti 3, Rossana Lorenzetti 3, Marinella Baroni 3

Urinary Incontinence. Lora Keeling and Byron Neale

Description. Section: Surgery Effective Date: October 15, 2014 Subsection: Surgery Original Policy Date: December 6, 2012 Subject:

Overactive Bladder Syndrome

By:Dr:ISHRAQ MOHAMMED

Urinary Incontinence in Women: Never an Acceptable Consequence of Aging

Medical Policy Title: Radiofrequency ARBenefits Approval: 10/19/2011

Lower urinary tract symptoms in female patients with pelvic organ prolapse: Efficacy of pelvic floor reconstruction

25-Feb-16 MANAGEMENT OF URINARY INCONTINENCE IN WOMEN.

OVERACTIVE BLADDER (OAB)

Overactive Bladder. Learning Objectives

Multiple Sclerosis. Véronique Phé, MD, PhD Pitié-Salpêtrière Academic Hospital Department of Urology Paris 6 University Paris, FRANCE

Taking Control of your Bladder, or. Don't make me laugh when laughter isn't the best medicine: a discussion on urinary incontinence

3/20/10. Prevalence of OAB Men: 16.0% Women: 16.9% Prevalence of OAB with incontinence (OAB wet) Men: 2.6% Women: 9.3% Dry. Population (millions) Wet

Functional anatomy of the female pelvic floor and lower urinary tract Stefano Floris, MD, PhD Department of Obstetrics and Gynaecology

Frequency of urinary incontinence with Pelvic organ prolapse and associated factors

INJINTERNATIONAL. Radiographic Position of the Electrode as a Predictor of the Outcome of InterStim Therapy. Original Article INTRODUCTION

MEDICAL POLICY SUBJECT: SACRAL NERVE STIMULATION. POLICY NUMBER: CATEGORY: Technology Assessment

Urodynamic Patterns of the Idiopathic Overactive Bladder

Does Urethral Competence Affect Urodynamic Voiding Parameters in Women With Prolapse?

Refractory Lower Urinary Tract Symptoms

Video-urodynamics. P J R Shah Institute of Urology and UCH

Transcription:

Kathleen C. Kobashi, MD, FACS Head, Section of Urology and Renal Transplantation Virginia Mason Medical Center, Seattle, WA

Disclosures Advisory Board and/or Speaker Allergan Medtronic Astellas AUA Guidelines Urodynamics, Member 2011-2014 Stress Incontinence, Chair, 2015-current

Urology at Virginia Mason

Introduction Prevalence of OAB Estimated > 500 million worldwide by 2018 1 Increases with age Prevalence of POP Overall: 2.9% 2 Increases with age 11% have surgery by age 80 3 1. Irwin DE, et al., BJU International 2011;108(7):1132-8. 2. Nygaard I, Barber M: JAMA 2008;300(11)L1311-6. 3. Olsen AL, et al.: Obstet Gynecol 1997;89(4):501-6.

OAB and POP in general population Risk factors for symptomatic OAB Symptoms of POP Prior surgery for POP or incontinence Age >75 years Overweight Postmenopausal status Smoking DeBoar TA, et al.: Int Urogyn J 2011.

Relationship between OAB and POP Do OAB and POP coexist? Can OAB exist without POP? Can POP cause OAB? Does repairing prolapse fix OAB?

Prevalence of OAB with POP

Can POP cause OAB? POP Urethral kinking Stretch receptors Urethral traction OAB DeBoar TA, et al.: Neurourol Urodyn 2010;29(1):30-9.

OAB and prolapse Prevalence of OAB higher with POP 1 POP is a risk factor for OAB 1 OAB resolves following prolapse repair 2 (but not in everybody) An F, et al.: Neurourol Urodyn 2014, Epub ahead of print. DeBoar TA, et al.: Neurourol Urodyn 2010;29(1):30-9.

Anatomy or function? OAB can be a primary condition OAB can be a secondary condition Or both

The questions at hand... Can we determine if it a problem of anatomy or function? Would that guide our decision? Does degree of bother play a role? Do we HAVE to treat stage II prolapse? Can we just treat the OAB? Risk of retention in the face of POP

Case scenario 58 year-old woman Urgency incontinence requiring 2 pads/day No SUI Mild obstructive symptoms Occasional hesitancy and intermittency Moderate force of stream Feels she empties

Pelvic examination Stage II anterior compartment prolapse Aa +1, Ba +1 Minimal posterior Ap -3, Bp -2 Minimal apical prolapse TVL 11 cm, C -9, D-10 Urethra mobile, no SUI Mild atrophic vaginitis

Urodynamics Filling cystometry Bladder capacity: 400cc Low amplitude detrusor overactivity Sensation normal No occult SUI

Pressure flow analysis Pves Multiphasic flow curve Maximum flow: 13 cc/sec Pdet Qmax: 24 cm H20 Minimal straining PVR: 110 cc Pab d Pdet EMG Flow

AUA/SUFU OAB Guidelines 1 st line Behavioral/dietary modification Physical therapy 2 nd line Antimuscarinics β-3 agonists 3 rd line Neuromodulation Onabotulinumtoxin A Gormley EA, et al.,: J Urol 2012;188(6 Suppl):2455-63.

1 st line therapy Behavioral therapy Bladder training Timed voiding Quick flicks Dietary modification Physical therapy May be combined with pharmacotherapy Gormley EA, et al.,: J Urol 2012;188(6 Suppl):2455-63.

2 nd line therapy Antimuscarinics β-3 agonists Limitations of drug use Side effects Duration of treatment Cost Gormley EA, et al.,: J Urol 2012;188(6 Suppl):2455-63.

This is the crossroads 1 st and 2 nd line therapies 3 rd line therapies Fix prolapse

Considerations Degree of urgency Degree of prolapse Degree of bother from each Preoperative emptying Risks of interventions

3 rd line therapy Neuromodulation Sacral Peripheral Tibial Nerve Stimulation (PTNS) OnabotulinumtoxinA injection Gormley EA, et al.,: J Urol 2012;188(6 Suppl):2455-63.

Prolapse reduction OAB Multi-study summary Pessary reduced OAB symptoms Up to 4 month follow up by questionnaire DeBoar TA, et al.: Neurourol Urodyn 2010;29(1):30-9.

Effect of POP on OAB resolution? n=235 women with POP and OAB Treated with tolterodine Conclusion: POP causative effect on OAB POP stage Pretreatment Post-treatment RR Stage I Stage II 184/184 (100%) 51/51 (100%) 26/84 (14.15%) 7.09 20/51 (39%) 2.55 Salvatore S et al., BJOG, 2007

Effect of POP repair on OAB n=175 with concomitant OAB and POP 133 anterior repair; 24 posterior OAB decreased significantly in both groups Anterior>posterior Dieter et al.: FPMRS J 2014.

Effect of POP repair on OAB Comprehensive review of literature Conclusion: In practically all studies, there was an improvement in OAB symptoms following POP surgery Implication: Link exists between OAB and POP Patil and Ducket: Curr Opin Obs Gynecol 2010.

in OAB sxs after POP repair Symptoms Stage I and II Stage III and IV Urgency 90% 85% Frequency 89% 85% Miranne et al., Int J Urol 2013;24(8):1303-8.

Postulation Women with high grade POP may be at higher risk for persistent OAB Irreversible changes to detrusor muscle? Flaws No PVR No information regarding obstruction No suggestion of how to treat persistent OAB Miranne et al., Int J Urol 2013;24(8):1303-8.

BeDri study Predictors of outcomes in OAB treatment Stop treatment Who would still be dry? Patients with greater anterior prolapse did better off med Conclusion: POP urethral kinking prevents urine from getting into urethra decreases OAB Richter HE et al,: Int J Urogynecol Pelvic Floor Dysfxn, 2009.

Literature variable Improvement of OAB seen in some (but not all) Higher stage POP Less likely to have resolution of OAB POP may either Cause OAB due to outlet obstruction OR Prevent OAB by not allowing urine to enter proximal urethra

The problem in the literature Lack of uniformity in: Definitions Patient populations Outcomes measures DeBoar TA, et al.: Neurourol Urodyn 2010;29(1):30-9.

What can we conclude? Minimum f/u 12 months 6/7 papers: significant OAB improvement 1/7 no improvement Still, OAB improved after POP surgery There must be a causal relationship DeBoar TA, et al.: Neurourol Urodyn 2010;29(1):30-9.

Bother matters OAB did not improve in all Unclear what predicted improvement Message: antimuscarinics may be considered in pts with OAB and POP if she is bothered by OAB (Converse may be true as well) DeBoar TA, et al.: Neurourol Urodyn 2010;29(1):30-9.

Theory on OAB and POP Unkinking of urethra may: relieve obstruction improve emptying decrease OAB POP repair Improved flow Decreased Pdet at Qmax Coates et al., BJU 1997.

3 rd line therapies Peripheral Tibial Nerve Stimulation (PTNS) Life-long therapy Literature limited in refractory OAB OnabotulinumtoxinA injection Already at risk for retention Sacral neuromodulation For refractory OAB and incomplete emptying But, for non-obstructive emptying dysfunction Life-long maintenance of device

Cumulative 3-year costs Treatment Cost (US $) PTNS 7,565 OnabotulinumtoxinA 11,748 Interstim 24,681 Vaginal POP repair 6,353 Martinson et al.: J Urol 2013. Medicare, CMS

Implications of intervention OAB treatment Adverse effects and cost of medications Retention Potential for resolution with surgery Prolapse repair Risks of surgery Persistence or exacerbation of OAB

Conclusion On OAB in the face of prolapse OAB first If OAB bothers her, but prolapse does not Prolapse first If both bother her If she is obstructed If unsure, consider pessary trial

A practical approach OAB and POP Treat OAB AUA/SUFU Guidelines If OAB persists Repair prolapse If OAB persists Repeat OAB Guidelines